Physician profile
Devika Aggarwal
NPI 1598389785
$928.60
in general payments reported to CMS, 2019-2025
11 companies · $770 in 2025
The $770 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $50.98 · 2024: $108 · 2025: $770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843 · Education: $85.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.10 |
| Education | $85.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $307.28 | 2025 | Mynx Control Venous |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $191.39 | 2025 | Lifevest |
| Heartflow, INC. | $184.00 | 2025 | |
| Medtronic, INC. | $70.15 | 2024 | Linq II, Corevalve Evolut R |
| Pfizer INC. | $39.95 | 2025 | |
| Ancora Heart, INC. | $26.73 | 2023 | Accucinch |
| Abiomed | $24.43 | 2024 | Impella |
| Daiichi Sankyo INC. | $24.25 | 2023 | Injectafer |
| Procyrion, INC. | $23.71 | 2025 | Aortix System |
| Bayer Healthcare Pharmaceuticals INC. | $23.56 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $13.15 | 2024 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devika Aggarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.